KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

8x8 (EGHT) Asset Writedowns and Impairment (2017 - 2025)

8X8 (EGHT) has disclosed Asset Writedowns and Impairment for 9 consecutive years, with -$628000.0 as the latest value for Q4 2025.

  • Quarterly Asset Writedowns and Impairment fell 502.56% to -$628000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $165000.0 through Dec 2025, down 98.47% year-over-year, with the annual reading at $1.8 million for FY2025, 83.25% down from the prior year.
  • Asset Writedowns and Impairment for Q4 2025 was -$628000.0 at 8X8, down from $85000.0 in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $11.0 million in Q4 2023, with the low at -$4.0 million in Q1 2021.
  • Average Asset Writedowns and Impairment over 5 years is $1.2 million, with a median of $400500.0 recorded in 2021.
  • The sharpest move saw Asset Writedowns and Impairment soared 1033.7% in 2024, then plummeted 502.56% in 2025.
  • Over 5 years, Asset Writedowns and Impairment stood at $748000.0 in 2021, then skyrocketed by 394.65% to $3.7 million in 2022, then skyrocketed by 197.3% to $11.0 million in 2023, then tumbled by 98.58% to $156000.0 in 2024, then tumbled by 502.56% to -$628000.0 in 2025.
  • According to Business Quant data, Asset Writedowns and Impairment over the past three periods came in at -$628000.0, $85000.0, and $290000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.